557 related articles for article (PubMed ID: 27270279)
1. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
[TBL] [Abstract][Full Text] [Related]
2. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Brüggemann RJ; Lefrant JY; Roberts JA
Clin Pharmacokinet; 2017 Sep; 56(9):1057-1068. PubMed ID: 28035589
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
Carrié C; Delzor F; Roure S; Dubuisson V; Petit L; Molimard M; Breilh D; Biais M
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964795
[TBL] [Abstract][Full Text] [Related]
6. A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration.
Sime FB; Lassig-Smith M; Starr T; Stuart J; Pandey S; Parker SL; Wallis SC; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658965
[TBL] [Abstract][Full Text] [Related]
7. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.
D'Arcy DM; Casey E; Gowing CM; Donnelly MB; Corrigan OI
BMC Pharmacol Toxicol; 2012 Nov; 13():14. PubMed ID: 23136834
[TBL] [Abstract][Full Text] [Related]
8. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
[TBL] [Abstract][Full Text] [Related]
9. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
Roberts JA; Udy AA; Bulitta JB; Stuart J; Jarrett P; Starr T; Lassig-Smith M; Roberts NA; Dunlop R; Hayashi Y; Wallis SC; Lipman J
J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
Fish DN; Teitelbaum I; Abraham E
Antimicrob Agents Chemother; 2005 Jun; 49(6):2421-8. PubMed ID: 15917542
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy.
Economou CJP; Kielstein JT; Czock D; Xie J; Field J; Richards B; Tallott M; Visser A; Koenig C; Hafer C; Schmidt JJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2018 Aug; 52(2):151-157. PubMed ID: 29526606
[TBL] [Abstract][Full Text] [Related]
13. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.
Patel K; Roberts JA; Lipman J; Tett SE; Deldot ME; Kirkpatrick CM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5868-73. PubMed ID: 21930888
[TBL] [Abstract][Full Text] [Related]
16. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
[TBL] [Abstract][Full Text] [Related]
17. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
Cirillo I; Vaccaro N; Balis D; Redman R; Matzke GR
Antimicrob Agents Chemother; 2011 Mar; 55(3):1187-93. PubMed ID: 21199922
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration.
Wenzler E; Bunnell KL; Bleasdale SC; Benken S; Danziger LH; Rodvold KA
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416553
[TBL] [Abstract][Full Text] [Related]
19. Does Critical Illness Change Levofloxacin Pharmacokinetics?
Roberts JA; Cotta MO; Cojutti P; Lugano M; Della Rocca G; Pea F
Antimicrob Agents Chemother; 2015 Dec; 60(3):1459-63. PubMed ID: 26666946
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy.
Chappell K; Kimmons LA; Haller JT; Canada RB; He H; Hudson JQ
J Crit Care; 2021 Feb; 61():216-220. PubMed ID: 33217623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
